Prevalence of metabolic syndrome in 25-45-year-old Novosibirsk dwellers

Voevoda M.I.; Kovalkova N.A.; Ragino Yu.I.; Travnikova N.Yu.; Denisova D.V.

doi:https://doi.org/10.17116/terarkh2016881051-56

Voevoda M.I.

Research Institute of Therapy and Prophylactic Medicine, Siberian Branch of the Russian Academy of Medical Sciences;
City Clinical Hospital No1, Novosibirsk, Russia

Kovalkova N.A.

Research Institute of Therapy and Preventive Medicine, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk, Russia

Ragino Yu.I.

Research Institute of Therapy and Preventive Medicine, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk, Russia

Travnikova N.Yu.

Research Institute of Internal and Preventive Medicine, Novosibirsk, Russia

Denisova D.V.

Institute of Internal and Preventive Medicine, Novosibirsk

Prevalence of metabolic syndrome in 25-45-year-old Novosibirsk dwellers

Authors:

Voevoda M.I., Kovalkova N.A., Ragino Yu.I., Travnikova N.Yu., Denisova D.V.

More about the authors

Journal: Therapeutic Archive. 2016;88(10): 51‑56

DOI: 10.17116/terarkh2016881051-56

Read: 2939 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Voevoda MI, Kovalkova NA, Ragino YuI, Travnikova NYu, Denisova DV. Prevalence of metabolic syndrome in 25-45-year-old Novosibirsk dwellers. Therapeutic Archive. 2016;88(10):51‑56. (In Russ.)
https://doi.org/10.17116/terarkh2016881051-56

Использование инфографики авторами научных работ

Close metadata

Abstract:

Aim. To study the prevalence of metabolic syndrome (MS) and its components in a 25-45-year-old Novosibirsk population. Subjects and methods. The Novosibirsk Research Institute of Internal and Preventive Medicine conducted a cross-sectional population-based survey in one of the typical districts of Novosibirsk in 2013-2015. The survey covered 346 men and 408 women. The criteria of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATP III, 2001), the International Diabetes Federation (IDF, 2005), the Joint Interim Statement (JIS, 2009), and the All-Russian Research Society of Cardiologists (ARRSC, 2009) were used to detect MS. According to the ARRSC criteria, MS was recorded if a waist circumference (WC) was >80 cm for women and >94 cm for men in conjunction with 2 of the following criteria: a blood pressure ≥130/85 mm Hg, triglycerides (TG) ≥1.7 mmol/l, high-density lipoprotein (HDL) cholesterol <1.0 mmol/l for men and <1.2 mmol/l for women, low-density lipoprotein (LDL) cholesterol >3.0 mmol/l, and plasma glucose level ≥6.1 mmol/l. Results. According to the 2009 ARRSC criteria, the prevalence of abdominal obesity, hypertension, hypertriglyceridemia, HDL hypocholestrolemia, LDL hypercholesterolemia, and high plasma glucose level was 42.6, 33.5, 17.5, 24.3, 64.8, and 29%, respectively. The prevalence of MS in 25-45-year-old Novosibirsk people was 17% (19.9% in men and 14.5% in women) according to the 2001 NCEP-ATP III, 27% (29.5% in men and 24.5% in women) according to the 2005 IDF criteria, 30% (35.8% in men and 25% in women) according to the 2009 JIS criteria, and 29.3% (33.2% in men and 26% in women) according to the 2009 ARRSC criteria, this was higher among men than women. There was an increase in the prevalence of MS with age. Conclusion. The highest prevalence of MS was 30 and 29.3% when using the 2009 JIS and the 2009 ARRSC criteria, respectively. Whatever the criterion was used, MS was more frequently recorded in men than women,

Keywords:

metabolic syndrome

prevalence

epidemiology

population

Authors:

Voevoda M.I.

Research Institute of Therapy and Prophylactic Medicine, Siberian Branch of the Russian Academy of Medical Sciences;
City Clinical Hospital No1, Novosibirsk, Russia

Kovalkova N.A.

Research Institute of Therapy and Preventive Medicine, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk, Russia

Ragino Yu.I.

Research Institute of Therapy and Preventive Medicine, Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk, Russia

Travnikova N.Yu.

Research Institute of Internal and Preventive Medicine, Novosibirsk, Russia

Denisova D.V.

Institute of Internal and Preventive Medicine, Novosibirsk

Close metadata

References:

James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prevent Rehabil. 2004;11(1):3-8. doi:10.1097/01.hjr.0000114707.27531.48
Jorgensen M, Borch-Johnsen K. The metabolic syndrome-is one global definition possible? Diab Med. 2004;21(10):1064-1065. doi:10.1111/j.1464-5491.2004.01400.x
Ford E. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care. 2005;28(11):2745-2749. doi:10.2337/diacare.28.11.2745
Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl A. Age specific prevalence of the metabolic syndrome by International Diabetes Federation and National Education Program: The Norwegian HUNT 2 study. BMC Public Health. 2007;7(1):220. doi:10.1186/1471-2458-7-220
Voevoda M, Ragino Yu, Chernyavskii A, Tsymbal S, Semaeva E, Polonskaya Ya, Ivanova M. The high prevalence of the metabolic syndrome in men with coronary atherosclerosis in Siberia. Rossiiskii kardiologicheskii zhurnal. 2010;1(81):65-69. (In Russ.)
Tunstall-Pedoe H. MONICA, monograph and multimedia sourcebook. Geneva: World Health Organization; 2003:237. doi:10.1258/jrsm.96.12.613
Ryden L, Standl E, Bartnik M, Berghe GVd, Betteridge J, M de Boer, Cosentino F, Jonsson B, Laakso V, Malmberg R, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88-136. doi:10.1093/eurheartj/ehl261
Pasternak R. National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III). ACC Cur J Rev. 2002;11(4):37-45. doi:10.1016/s1062-1458(02)00670-0
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diab Med. 2006;23(5):469-480. doi:10.1111/j.1464-5491.2006.01858.x
Alberti KG, Eckel RH, Grundy SM, Zimmet P, Cleeman J, Donato K, Fruchart J, James W, Loria C, Smith S. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. doi:10.1161/circulationaha.109.192644
Recommendations of experts of Russian Scientific Society of Cardiologists on diagnosis and treatment of metabolic syndrome. SECOND REVISION. Prakticheskaya meditsina. 2010;5(44):81-101. (In Russ.)
Ford ES, Giles WН, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey. Obstet Gynecol Survey. 2002;57(9):576-577. doi:10.1097/00006254-200209000-00017
Nikitin Yu, Kazeka G, Simonova G. Prevalence of Components of Metabolic Syndrome X in Non-Organized Urban Population. Kardiologiya. 2001;9(41):37-40. (In Russ.)
Simonova G, Mustafina S, Pechenkina E. The metabolic syndrome prevalence in Siberia: population-based study in Novosibirsk. Byulleten' Sibirskogo otdeleniya Rossiiskoi Akademii meditsinskikh nauk. 2011;5(31):100-106. (In Russ.)
Erina A, Libis R, Isaeva E, Savshin D, Rotar O, Solntsev V, Zagranichnaya S, Konradi A, Shlyakhto E. Prevalence of metabolic syndrome in cities of Russian Federation. J Hypertens. 2011;29:е155. doi:10.1097/00004872-201106001-00391
Mattsson N, Rönnemaa T, Juonala M, Viikari J, Raitakari O. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med. 2007;261(2):159-169. doi:10.1111/j.1365 2796.2006.01752.x
Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano F, Grassi G, Zanchetti A, Sega R. Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis. Hypertension. 2006;49(1):40-47. doi:10.1161/01.hyp.0000251933.22091.24
Empana JP, Jouver X. Metabolic syndrome and risk of sudden cardiac death in asymptomatic subjects. Mets Insights. 2006;9:11-15.
Shishkin S, Mustafina S, Shcherbakova L, Simonova G. Metabolic syndrome and risk of stroke in the population of Novosibirsk. Kardiovaskulyarnaya terapiya i profilaktika. 2014;13(3):53-57. (In Russ.)
Maharlouei N, Bellissimo N, Ahmadi S, Lankarani, K. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric. 2012;16(5):561-567. doi:10.3109/13697137.2012.727504
Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky V, Grjibovski A. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010;10(1):23. doi:10.1186/1471-2458-10-23
Malutina S. Desyatiletnie trendy i kogortnoe issledovanie konventsionnykh faktorov riska serdechno-sosudistykh zabolevanii v gorodskoi sibirskoi populyatsii: (po materialam proekta WHO MONICA) [abstract of a dissertation]. Novosibirsk; 2001. (In Russ.)